000			01468nam\a2200361\a\4500
001			57918
005			20260728113657.0
008			260728s2009 nyua b 001 0 eng
020			_a9781420088496 _qhardcover : alk. paper
020			_a1420088491 _qhardcover : alk. paper
040			_aDNLM/DLC _cDLC _dBTCTA _dBAKER _dYDXCP _dNLM _dC#P _dBWX _dBD-DhIUB
082	0	0	_a615.1 _222 _bN5321
245	0	0	_aNew drug approval process / _cedited by Richard A. Guarino.
250			_a5th ed.
260			_aNew York : _bInforma Healthcare, _cc2009.
300			_axviii, 529 p. : _bill. ; _c24 cm.
490	1		_aDrugs and the pharmaceutical sciences ; _vv. 190
504			_aIncludes bibliographical references and index.
526			_aPHR _bphr _lPHAR
541			_aOmni concept
650		0	_aDrug approval _zUnited States.
650		0	_aDrugs _xTesting _xStandards.
650		0	_aDrugs _xTesting _xGovernment policy _zUnited States.
650		0	_aNew products _xGovernment policy _zUnited States.
650	1	2	_aDrug Evaluation _xstandards _zUnited States.
650	2	2	_aClinical Trials as Topic _xstandards _zUnited States.
650	2	2	_aDrug Approval _zUnited States.
700	1		_aGuarino, Richard A., _d1935-
830		0	_aDrugs and the pharmaceutical sciences ; _vv. 190.
942			_2ddc _cBK
999			_c57918 _d58092